Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
194M
-
Number of holders
-
422
-
Total 13F shares, excl. options
-
174M
-
Shares change
-
-861K
-
Total reported value, excl. options
-
$17.4B
-
Value change
-
-$79.1M
-
Put/Call ratio
-
1.11
-
Number of buys
-
217
-
Number of sells
-
-176
-
Price
-
$100.27
Significant Holders of INCYTE CORP - COMMON STOCK (INCY) as of Q4 2016
495 filings reported holding INCY - INCYTE CORP - COMMON STOCK as of Q4 2016.
INCYTE CORP - COMMON STOCK (INCY) has 422 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 174M shares
of 194M outstanding shares and own 89.72% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (23.5M shares), WELLINGTON MANAGEMENT GROUP LLP (18.1M shares), VANGUARD GROUP INC (12.6M shares), Capital World Investors (10.3M shares), PRICE T ROWE ASSOCIATES INC /MD/ (7.03M shares), Capital International Investors (6.02M shares), BlackRock Fund Advisors (4.44M shares), BlackRock Institutional Trust Company, N.A. (4.44M shares), BB BIOTECH AG (3.88M shares), and SANDS CAPITAL MANAGEMENT, LLC (3.65M shares).
This table shows the top 422 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.